• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

伴有EGFR基因突变的肺腺癌转移至子宫颈:一例报告

Lung adenocarcinoma with EGFR gene mutation metastatic to the uterine cervix: A case report.

作者信息

Wang Yong, Chen Lin, Wang Zhi, Liu Shubin

机构信息

Department of Medical Oncology, The First Affiliated Hospital of Nanchang University, 17 Yongwai Zheng Road, Nanchang.

Department of Medical Oncology, The Affiliated Ganzhou Hospital of Nanchang University (Ganzhou People's Hospital), 16 Meiguan Road, Ganzhou.

出版信息

Medicine (Baltimore). 2020 Oct 16;99(42):e22636. doi: 10.1097/MD.0000000000022636.

DOI:10.1097/MD.0000000000022636
PMID:33080701
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7572012/
Abstract

INTRODUCTION

The cervix is a rare site of metastasis from advanced lung adenocarcinoma. Driven gene detection is particularly important for the treatment of advanced lung adenocarcinoma.

PATIENT CONCERNS

A 49-year-old Chinese female was sent to our hospital because of lumbago and sacroiliac joint pain; she was unable to walk and had vaginal bleeding. The following examinations were performed: imaging, colposcopy, bronchoscopy, immunohistochemistry and next-generation sequencing.

DIAGNOSIS

According to the clinical manifestations and the examination results, the diagnosis was lung adenocarcinoma with cervical, brain, adrenal gland and bone metastases. More importantly, EGFR gene mutations (del19) were detected in both the primary lung lesion and uterine cervical biopsy specimen.

INTERVENTIONS

Osimertinib was chosen as the first-line treatment.

OUTCOMES

Lumbago and sacroiliac joint pain were significantly relieved. The levels of tumor markers decreased. Primary injuries and metastatic sites were significantly reduced.

CONCLUSION

Physicians should be alert to the signals of vaginal bleeding and consider that primary lung adenocarcinoma may metastasize to the uterine cervix.

摘要

引言

宫颈是晚期肺腺癌罕见的转移部位。驱动基因检测对晚期肺腺癌的治疗尤为重要。

患者情况

一名49岁中国女性因腰痛和骶髂关节疼痛被送至我院;她无法行走且有阴道出血。进行了以下检查:影像学检查、阴道镜检查、支气管镜检查、免疫组化检查和二代测序。

诊断

根据临床表现及检查结果,诊断为肺腺癌伴宫颈、脑、肾上腺及骨转移。更重要的是,在原发性肺部病灶和子宫颈活检标本中均检测到表皮生长因子受体(EGFR)基因突变(19号外显子缺失)。

干预措施

选择奥希替尼作为一线治疗药物。

结果

腰痛和骶髂关节疼痛明显缓解。肿瘤标志物水平下降。原发性损伤和转移部位明显缩小。

结论

医生应警惕阴道出血信号,并考虑原发性肺腺癌可能转移至子宫颈。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/7572012/b30660e89ecc/medi-99-e22636-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/7572012/545facf759e3/medi-99-e22636-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/7572012/40fdf4549fe6/medi-99-e22636-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/7572012/eb29bd34b677/medi-99-e22636-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/7572012/b30660e89ecc/medi-99-e22636-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/7572012/545facf759e3/medi-99-e22636-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/7572012/40fdf4549fe6/medi-99-e22636-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/7572012/eb29bd34b677/medi-99-e22636-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2eb0/7572012/b30660e89ecc/medi-99-e22636-g004.jpg

相似文献

1
Lung adenocarcinoma with EGFR gene mutation metastatic to the uterine cervix: A case report.伴有EGFR基因突变的肺腺癌转移至子宫颈:一例报告
Medicine (Baltimore). 2020 Oct 16;99(42):e22636. doi: 10.1097/MD.0000000000022636.
2
Next-generation sequencing assisted diagnosis of cervical metastasis in EGFR-mutated lung adenocarcinoma: A case report.下一代测序辅助诊断 EGFR 突变型肺腺癌的宫颈转移:一例报告。
Thorac Cancer. 2021 Oct;12(19):2622-2627. doi: 10.1111/1759-7714.14143. Epub 2021 Sep 9.
3
Poor effect of osimertinib on EGFR exon 20 insertion-positive lung adenocarcinoma: A case report.奥希替尼对表皮生长因子受体第20外显子插入阳性肺腺癌疗效不佳:一例报告
Medicine (Baltimore). 2020 Oct 16;99(42):e22628. doi: 10.1097/MD.0000000000022628.
4
Clinical efficacy analysis of Osimertinib treatment for a patient with leptomeningeal metastasis of EGFR+ non-small cell lung cancer without the T790M mutation.奥希替尼治疗1例无T790M突变的EGFR+非小细胞肺癌软脑膜转移患者的临床疗效分析
Ann Palliat Med. 2019 Nov;8(5):525-531. doi: 10.21037/apm.2019.10.13.
5
The role of comprehensive analysis with circulating tumor DNA in advanced non-small cell lung cancer patients considered for osimertinib treatment.在考虑使用奥希替尼治疗的晚期非小细胞肺癌患者中,采用循环肿瘤 DNA 进行综合分析的作用。
Cancer Med. 2021 Jun;10(12):3873-3885. doi: 10.1002/cam4.3929. Epub 2021 May 12.
6
Late recurrence of lung adenocarcinoma harboring EGFR exon 20 insertion (A763_Y764insFQEA) mutation successfully treated with osimertinib.奥希替尼成功治疗携 EGFR 外显子 20 插入(A763_Y764insFQEA)突变的肺腺癌晚期复发。
Cancer Genet. 2021 Aug;256-257:57-61. doi: 10.1016/j.cancergen.2021.04.001. Epub 2021 Apr 10.
7
A promising response to osimertinib in a patient with erlotinib-resistant lung adenocarcinoma with an uncommon EGFR mutation.一名患有对厄洛替尼耐药的肺腺癌且具有罕见表皮生长因子受体(EGFR)突变的患者对奥希替尼有显著反应。
BMJ Case Rep. 2018 Jun 4;2018:bcr-2017-219770. doi: 10.1136/bcr-2017-219770.
8
Clearing of circulating tumour DNA predicts clinical response to osimertinib in EGFR mutated lung cancer patients.循环肿瘤 DNA 清除预测 EGFR 突变型肺癌患者对奥希替尼的临床反应。
Lung Cancer. 2020 May;143:67-72. doi: 10.1016/j.lungcan.2020.03.020. Epub 2020 Mar 19.
9
Molecular follow-up of first-line treatment by osimertinib in lung cancer: Importance of using appropriate tools for detecting EGFR resistance mutation C797S.奥希替尼一线治疗肺癌的分子随访:使用合适的工具检测 EGFR 耐药突变 C797S 的重要性。
Cancer Genet. 2021 Aug;256-257:158-161. doi: 10.1016/j.cancergen.2021.06.001. Epub 2021 Jun 10.
10
Detection of Meningeal Metastasis in the Cerebrospinal Fluid in Lung Adenocarcinoma: Case Report.肺腺癌脑脊液中脑膜转移的检测:病例报告
Clin Lung Cancer. 2020 Sep;21(5):e493-e496. doi: 10.1016/j.cllc.2020.04.010. Epub 2020 Apr 15.

引用本文的文献

1
[Uterine and Adnexal Metastasis of Lung Adenocarcinoma: 
A Case Report and Literature Review].[肺腺癌子宫及附件转移:一例报告及文献复习]
Zhongguo Fei Ai Za Zhi. 2024 Dec 20;27(12):961-966. doi: 10.3779/j.issn.1009-3419.2024.102.40.
2
Next-generation sequencing assisted diagnosis of cervical metastasis in EGFR-mutated lung adenocarcinoma: A case report.下一代测序辅助诊断 EGFR 突变型肺腺癌的宫颈转移:一例报告。
Thorac Cancer. 2021 Oct;12(19):2622-2627. doi: 10.1111/1759-7714.14143. Epub 2021 Sep 9.

本文引用的文献

1
ALK rearrangement in lung adenocarcinoma with concurrent cervix and breast metastases: A case report.肺腺癌伴宫颈和乳腺转移中 ALK 重排:一例报告。
Thorac Cancer. 2018 Nov;9(11):1513-1518. doi: 10.1111/1759-7714.12848. Epub 2018 Aug 24.
2
The high diagnostic accuracy of combined test of thyroid transcription factor 1 and Napsin A to distinguish between lung adenocarcinoma and squamous cell carcinoma: a meta-analysis.甲状腺转录因子1和Napsin A联合检测鉴别肺腺癌与肺鳞癌的高诊断准确性:一项荟萃分析
PLoS One. 2014 Jul 8;9(7):e100837. doi: 10.1371/journal.pone.0100837. eCollection 2014.
3
New strategies in lung cancer: epigenetic therapy for non-small cell lung cancer.
肺癌的新策略:非小细胞肺癌的表观遗传治疗
Clin Cancer Res. 2014 May 1;20(9):2244-8. doi: 10.1158/1078-0432.CCR-13-2088. Epub 2014 Mar 18.
4
ALK inhibitors: a new targeted therapy in the treatment of advanced NSCLC.ALK 抑制剂:晚期 NSCLC 治疗的一种新的靶向治疗方法。
Target Oncol. 2013 Mar;8(1):55-67. doi: 10.1007/s11523-012-0250-9. Epub 2013 Jan 17.
5
Adenocarcinoma metastatic to the uterine cervix: a case series.转移至子宫颈的腺癌:病例系列
J Obstet Gynaecol Res. 2012 Mar;38(3):541-9. doi: 10.1111/j.1447-0756.2011.01747.x. Epub 2012 Feb 22.
6
Napsin A, a new marker for lung adenocarcinoma, is complementary and more sensitive and specific than thyroid transcription factor 1 in the differential diagnosis of primary pulmonary carcinoma: evaluation of 1674 cases by tissue microarray. napsin A,一种新的肺腺癌标志物,在原发性肺癌的鉴别诊断中与甲状腺转录因子 1 相比具有互补性,且更敏感、更特异:应用组织微阵列技术检测 1674 例病例。
Arch Pathol Lab Med. 2012 Feb;136(2):163-71. doi: 10.5858/arpa.2011-0320-OA.
7
Metastatic uterine cervical cancer originating in the lung: a case report.转移性宫颈癌起源于肺部:一例报告。
Gynecol Obstet Invest. 2009;68(4):269-71. doi: 10.1159/000241297. Epub 2009 Sep 24.
8
A rare case of primary lung adenocarcinoma detected by routine liquid-based cervical cytology.通过常规液基宫颈细胞学检查发现的原发性肺腺癌罕见病例。
Lung Cancer. 2007 Nov;58(2):282-5. doi: 10.1016/j.lungcan.2007.04.017. Epub 2007 Jun 12.
9
Lung carcinoma metastatic to the ovary: a clinicopathologic study of 32 cases emphasizing their morphologic spectrum and problems in differential diagnosis.肺腺癌转移至卵巢:32例临床病理研究,重点关注其形态学谱及鉴别诊断问题。
Am J Surg Pathol. 2005 Aug;29(8):997-1006.
10
Extragenital adenocarcinoma metastatic to the cervix uteri.转移至子宫颈的生殖器外腺癌。
Am J Obstet Gynecol. 1972 Dec 15;114(8):1104-5. doi: 10.1016/0002-9378(72)90881-2.